Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-01

Clinical Trial Update: Parenteral Artesunate Compared to Quinine as a Cause of Late Anaemia in African Children With Malaria [Phase 4]

View source ↗

Summary

Phase 4 trial comparing parenteral artesunate with quinine to assess risk of late anaemia in African children with malaria; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artesunate (artesunate)
  • Quinine (quinine)

Snippet

Sponsor: University of Oxford | Conditions: Anaemia | Phase 4 | Status: COMPLETED